154 related articles for article (PubMed ID: 28545096)
1. Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine).
Muñoz-Esquerre M; Aliagas E; López-Sánchez M; Escobar I; Huertas D; Penín R; Dorca J; Santos S
PLoS One; 2017; 12(5):e0177218. PubMed ID: 28545096
[TBL] [Abstract][Full Text] [Related]
2. Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD.
Aliagas E; Muñoz-Esquerre M; Cuevas E; Careta O; Huertas D; López-Sánchez M; Escobar I; Dorca J; Santos S
Respir Res; 2018 May; 19(1):103. PubMed ID: 29807526
[TBL] [Abstract][Full Text] [Related]
3. [The changes and significance of interleukin-16 and CXC chemokine receptor 3 expression in pulmonary artery of smokers with chronic obstructive pulmonary disease].
Wan P; Zhong XN; He ZY; Zhang JQ; Liu GN; Lao QF
Zhonghua Nei Ke Za Zhi; 2009 Oct; 48(10):841-5. PubMed ID: 20079227
[TBL] [Abstract][Full Text] [Related]
4. Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease.
Muñoz-Esquerre M; López-Sánchez M; Escobar I; Huertas D; Penín R; Molina-Molina M; Manresa F; Dorca J; Santos S
PLoS One; 2016; 11(4):e0152987. PubMed ID: 27046203
[TBL] [Abstract][Full Text] [Related]
5. [Interleukin-17 expression and significance in normal lung function smokers and chronic obstructive pulmonary disease patients].
Zhang JQ; Lao QF; Chu SY; Bai J; Zhong XN
Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1431-5. PubMed ID: 20646637
[TBL] [Abstract][Full Text] [Related]
6. Increased S100A4 expression in the vasculature of human COPD lungs and murine model of smoke-induced emphysema.
Reimann S; Fink L; Wilhelm J; Hoffmann J; Bednorz M; Seimetz M; Dessureault I; Troesser R; Ghanim B; Klepetko W; Seeger W; Weissmann N; Kwapiszewska G
Respir Res; 2015 Oct; 16():127. PubMed ID: 26483185
[TBL] [Abstract][Full Text] [Related]
7. [Expression and significance of hypoxia-inducible factor-1α in patients with chronic obstructive pulmonary disease and smokers with normal lung function].
Tao H; Luo W; Pei H; Zhu S; Zhang M; Chen B; He J; Zhang M; Zhou R
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):852-5. PubMed ID: 25108440
[TBL] [Abstract][Full Text] [Related]
8. [Expression of pulmonary artery connective tissue growth factor and pulmonary artery remodeling in smokers and patients with chronic obstructive pulmonary disease].
Tian F; Xu YJ; Zhang ZX; Hu J
Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):298-301. PubMed ID: 17637269
[TBL] [Abstract][Full Text] [Related]
9. Possible role of Krüppel-like factor 5 in the remodeling of small airways and pulmonary vessels in chronic obstructive pulmonary disease.
Abe K; Sugiura H; Hashimoto Y; Ichikawa T; Koarai A; Yamada M; Numakura T; Onodera K; Tanaka R; Sato K; Yanagisawa S; Okazaki T; Tamada T; Kikuchi T; Ichinose M
Respir Res; 2016 Jan; 17():7. PubMed ID: 26792671
[TBL] [Abstract][Full Text] [Related]
10. Change of extracellular signal-regulated kinase expression in pulmonary arteries from smokers with and without chronic obstructive pulmonary disease.
Liu K; Liu XS; Yu MQ; Xu YJ
Exp Lung Res; 2013; 39(4-5):162-72. PubMed ID: 23614701
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease.
Demedts IK; Bracke KR; Van Pottelberge G; Testelmans D; Verleden GM; Vermassen FE; Joos GF; Brusselle GG
Am J Respir Crit Care Med; 2007 May; 175(10):998-1005. PubMed ID: 17332482
[TBL] [Abstract][Full Text] [Related]
12. Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease.
Sin DD; Miller BE; Duvoix A; Man SF; Zhang X; Silverman EK; Connett JE; Anthonisen NA; Wise RA; Tashkin D; Celli BR; Edwards LD; Locantore N; Macnee W; Tal-Singer R; Lomas DA;
Am J Respir Crit Care Med; 2011 May; 183(9):1187-92. PubMed ID: 21216880
[TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of immunoglobulin free light chains in serum and lung tissues from patients with chronic obstructive pulmonary disease].
Zhang M; Tao HC; Li YQ; Pei HS; Zhu SY; Chen B; Zhou RJ; Zhang MW
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):945-9. PubMed ID: 24503428
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA Dysregulation in Pulmonary Arteries from Chronic Obstructive Pulmonary Disease. Relationships with Vascular Remodeling.
Musri MM; Coll-Bonfill N; Maron BA; Peinado VI; Wang RS; Altirriba J; Blanco I; Oldham WM; Tura-Ceide O; García-Lucio J; de la Cruz-Thea B; Meister G; Loscalzo J; Barberà JA
Am J Respir Cell Mol Biol; 2018 Oct; 59(4):490-499. PubMed ID: 29757677
[TBL] [Abstract][Full Text] [Related]
15. Imbalance in the Expression of Genes Associated with Purinergic Signalling in the Lung and Systemic Arteries of COPD Patients.
Careta O; Cuevas E; Muñoz-Esquerre M; López-Sánchez M; Pascual-González Y; Dorca J; Aliagas E; Santos S
Sci Rep; 2019 Feb; 9(1):2796. PubMed ID: 30808894
[TBL] [Abstract][Full Text] [Related]
16. Expression variations of connective tissue growth factor in pulmonary arteries from smokers with and without chronic obstructive pulmonary disease.
Zhou SJ; Li M; Zeng DX; Zhu ZM; Hu XW; Li YH; Wang R; Sun GY
Sci Rep; 2015 Feb; 5():8564. PubMed ID: 25708588
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profile of angiogenic factors in pulmonary arteries in COPD: relationship with vascular remodeling.
García-Lucio J; Argemi G; Tura-Ceide O; Diez M; Paul T; Bonjoch C; Coll-Bonfill N; Blanco I; Barberà JA; Musri MM; Peinado VI
Am J Physiol Lung Cell Mol Physiol; 2016 Apr; 310(7):L583-92. PubMed ID: 26801565
[TBL] [Abstract][Full Text] [Related]
18. [The expression of hypoxia-inducible factor-1alpha and its hydroxylases in pulmonary arteries of patient with chronic obstructive pulmonary disease].
Chen YR; Dai AG; Hu RC; Kong CC
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 May; 28(3):234-8. PubMed ID: 22860423
[TBL] [Abstract][Full Text] [Related]
19. Changes of protein kinase Calpha and cyclin D1 expressions in pulmonary arteries from smokers with and without chronic obstructive pulmonary disease.
Xaing M; Liu X; Zeng D; Wang R; Xu Y
J Huazhong Univ Sci Technolog Med Sci; 2010 Apr; 30(2):159-64. PubMed ID: 20407865
[TBL] [Abstract][Full Text] [Related]
20. Characterization of pulmonary vascular remodeling and MicroRNA-126-targets in COPD-pulmonary hypertension.
Goel K; Egersdorf N; Gill A; Cao D; Collum SD; Jyothula SS; Huang HJ; Sauler M; Lee PJ; Majka S; Karmouty-Quintana H; Petrache I
Respir Res; 2022 Dec; 23(1):349. PubMed ID: 36522710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
